Although we focused on PRCC-TFE3 fusion-affected tRCC organoids as a representative lineage, it is likely that the same general techniques could be adapted to produce other fusion types in the future. The gene discussed is PRCC; the disease is renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.